Jess Moerland Successfully Defends Her Dissertation

Jess Moerland successfully defended her dissertation Jan. 30. Her topic was “Pharmacological Nrf2 Activation Reprograms the Immune Microenvironment and Decreases Tumor Burden in KRAS-Driven Lung Cancer." Congratulations Dr. Moerland on a job well done.